Latest Insider Transactions at Invesco Ltd. (IVZ)
This section provides a real-time view of insider transactions for Invesco Ltd. (IVZ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Invesco Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Invesco Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 15
2022
|
Christopher C Womack Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,930
+43.32%
|
-
|
May 15
2022
|
Phoebe A Wood Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,930
+14.49%
|
-
|
May 10
2022
|
Terry Vacheron Chief Accounting Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+27.22%
|
$68,000
$17.4 P/Share
|
Apr 29
2022
|
Mm Asset Management Holding LLC |
BUY
Other acquisition or disposition
|
Indirect |
4,114,098
+4.91%
|
-
|
Apr 29
2022
|
Denis Kessler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,311
+1.69%
|
-
|
Apr 04
2022
|
Trian Fund Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,062
+0.45%
|
$5,751,426
$23.46 P/Share
|
Apr 01
2022
|
Trian Fund Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,474,538
+2.59%
|
$33,914,374
$23.13 P/Share
|
Mar 31
2022
|
Trian Fund Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,000,000
+3.57%
|
$46,000,000
$23.07 P/Share
|
Mar 30
2022
|
Trian Fund Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,500,000
+2.8%
|
$34,500,000
$23.36 P/Share
|
Mar 29
2022
|
Trian Fund Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,273,501
+2.46%
|
$29,290,523
$23.2 P/Share
|
Mar 28
2022
|
Trian Fund Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
756,419
+1.51%
|
$16,641,218
$22.15 P/Share
|
Mar 25
2022
|
Trian Fund Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
720,080
+1.46%
|
$15,841,760
$22.01 P/Share
|
Mar 24
2022
|
Trian Fund Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
682,437
+1.41%
|
$14,331,177
$21.77 P/Share
|
Mar 23
2022
|
Trian Fund Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,026,508
+2.13%
|
$21,556,668
$21.52 P/Share
|
Mar 08
2022
|
Gregory Mc Greevey Senior Managing Director |
SELL
Open market or private sale
|
Direct |
200,000
-43.44%
|
$3,800,000
$19.6 P/Share
|
Mar 08
2022
|
Massachusetts Mutual Life Insurance CO |
BUY
Open market or private purchase
|
Direct |
1,378,433
+14.48%
|
$26,190,227
$19.59 P/Share
|
Mar 07
2022
|
Massachusetts Mutual Life Insurance CO |
BUY
Open market or private purchase
|
Direct |
1,378,433
+33.51%
|
$24,811,794
$18.65 P/Share
|
Mar 04
2022
|
Massachusetts Mutual Life Insurance CO |
BUY
Open market or private purchase
|
Direct |
1,349,650
+49.86%
|
$25,643,350
$19.01 P/Share
|
Mar 01
2022
|
Martin L Flanagan President & CEO |
SELL
Open market or private sale
|
Direct |
189,708
-28.0%
|
$3,604,452
$19.51 P/Share
|
Feb 28
2022
|
Annette Lege Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,755
-3.3%
|
$78,855
$21.24 P/Share
|
Feb 28
2022
|
Annette Lege Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,015
+6.57%
|
-
|
Feb 28
2022
|
Kevin M Carome SMD and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
30,006
-4.57%
|
$630,126
$21.24 P/Share
|
Feb 28
2022
|
Kevin M Carome SMD and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
64,408
+4.79%
|
-
|
Feb 28
2022
|
Laura Allison Dukes Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,621
-1.29%
|
$76,041
$21.24 P/Share
|
Feb 28
2022
|
Laura Allison Dukes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
49,435
+14.98%
|
-
|
Feb 28
2022
|
Martin L Flanagan President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
123,087
-15.37%
|
$2,584,827
$21.24 P/Share
|
Feb 28
2022
|
Martin L Flanagan President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
347,027
+19.3%
|
-
|
Feb 28
2022
|
Mark F Giuliano SMD & Chief Adm Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,972
-8.38%
|
$188,412
$21.24 P/Share
|
Feb 28
2022
|
Mark F Giuliano SMD & Chief Adm Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,598
+17.43%
|
-
|
Feb 28
2022
|
Jennifer Krevitt SMD & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
23,540
+50.0%
|
-
|
Feb 28
2022
|
Gregory Mc Greevey Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
55,354
-10.73%
|
$1,162,434
$21.24 P/Share
|
Feb 28
2022
|
Gregory Mc Greevey Senior Managing Director |
BUY
Grant, award, or other acquisition
|
Direct |
133,816
+12.1%
|
-
|
Feb 28
2022
|
Andrew Schlossberg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,231
-6.8%
|
$508,851
$21.24 P/Share
|
Feb 28
2022
|
Andrew Schlossberg President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
107,503
+13.92%
|
-
|
Feb 28
2022
|
Douglas J Sharp Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,004
-19.64%
|
$105,084
$21.24 P/Share
|
Feb 28
2022
|
Andrew Tak Shing Lo Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
119,772
+7.25%
|
-
|
Jan 27
2022
|
Denis Kessler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,744
+2.28%
|
-
|
Dec 13
2021
|
Peltz Nelson Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
8,718,084
+4.8%
|
$87,180,840
$10.58 P/Share
|
Dec 13
2021
|
Garden Edward P Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
8,718,084
+4.8%
|
$87,180,840
$10.58 P/Share
|
Nov 04
2021
|
Colin Meadows Senior Managing Director |
SELL
Open market or private sale
|
Direct |
47,210
-25.78%
|
$1,180,250
$25.84 P/Share
|
Nov 01
2021
|
Massachusetts Mutual Life Insurance CO |
BUY
Open market or private purchase
|
Direct |
7,582
+50.0%
|
$197,132
$26.15 P/Share
|
Oct 28
2021
|
Denis Kessler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,719
+3.59%
|
$67,975
$25.49 P/Share
|
Sep 13
2021
|
Andrew Tak Shing Lo Senior Managing Director |
SELL
Open market or private sale
|
Direct |
150,000
-39.94%
|
$3,600,000
$24.91 P/Share
|
Aug 31
2021
|
Douglas J Sharp Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
7,099
-21.79%
|
$177,475
$25.32 P/Share
|
Aug 31
2021
|
Douglas J Sharp Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,104
+31.68%
|
-
|
Aug 31
2021
|
Andrew Schlossberg President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,800
-2.76%
|
$520,000
$25.32 P/Share
|
Aug 31
2021
|
Andrew Schlossberg President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
46,118
+5.72%
|
-
|
Jul 29
2021
|
Denis Kessler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,419
+4.63%
|
$82,056
$24.35 P/Share
|
May 15
2021
|
Sarah Beshar Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,807
+9.02%
|
-
|
May 15
2021
|
Thomas M Finke Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,807
+43.01%
|
-
|